MetLife, Inc.

NYSE:MET Rapport sur les actions

Capitalisation boursière : US$59.0b

MetLife Croissance future

Future contrôle des critères 1/6

MetLife devrait augmenter ses bénéfices et son chiffre d'affaires de 13.2% et de 4.4% par an respectivement. Le BPA devrait croître de de 16.1% par an. Le rendement des capitaux propres devrait être 16% dans 3 ans.

Informations clés

13.2%

Taux de croissance des bénéfices

16.1%

Taux de croissance du BPA

Insurance croissance des bénéfices11.7%
Taux de croissance des recettes4.4%
Rendement futur des capitaux propres16.0%
Couverture par les analystes

Good

Dernière mise à jour21 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

MetLife, Inc.'s (NYSE:MET) P/E Still Appears To Be Reasonable

Sep 24
MetLife, Inc.'s (NYSE:MET) P/E Still Appears To Be Reasonable

MetLife: One Of The Best Life Insurance Stocks

Sep 23

Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield

Jul 09

MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood

Jun 26

Increases to CEO Compensation Might Be Put On Hold For Now at MetLife, Inc. (NYSE:MET)

Jun 12
Increases to CEO Compensation Might Be Put On Hold For Now at MetLife, Inc. (NYSE:MET)

MetLife (NYSE:MET) Is Increasing Its Dividend To $0.545

Apr 27
MetLife (NYSE:MET) Is Increasing Its Dividend To $0.545

MetLife: Healthy But Lacks Clear Advantages

Apr 18

MetLife, Inc.'s (NYSE:MET) P/E Is On The Mark

Apr 18
MetLife, Inc.'s (NYSE:MET) P/E Is On The Mark

MetLife: A Safe Bet To Hold As Future Earnings Growth Expected, And Tailwind From Rate Environment

Feb 03

MetLife: Expected Net Investment Growth For Upcoming Earnings

Jan 26

MetLife, Inc.'s (NYSE:MET) P/S Is On The Mark

Jan 15
MetLife, Inc.'s (NYSE:MET) P/S Is On The Mark

MetLife: Strong Capital Returns Make Shares Attractive (Ratings Upgrade)

Nov 15

MetLife: Disappointing Growth But Safe Dividend

Oct 26

MetLife: Neutral Rating Maintained, As Stock Remains Overvalued

Aug 18

MetLife: An Investment That Ensures Portfolios

Jul 12

MetLife institutional asset management arm to acquire Raven Capital

Feb 07

MetLife Q4 2022 Earnings Preview

Jan 31

MetLife declares $0.50 dividend

Jan 10

MetLife Is Trading Favorably On The Market

Dec 24

Looking Past Interest Rate Volatility Reveals MetLife Is A Hold

Oct 11

MetLife to acquire ESG-focused fixed income manager, Affirmative Investment

Aug 29

MetLife: Investors Should Look Past The Noisy Q2 2022 Results

Aug 12

MetLife declares $0.50 dividend

Jul 11

Prévisions de croissance des bénéfices et des revenus

NYSE:MET - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/202678,3506,333N/A9,0996
12/31/202576,1666,0784,4009,0967
12/31/202473,0104,603N/A8,7087
9/30/202471,3443,56115,16915,169N/A
6/30/202468,7702,70814,47514,475N/A
3/31/202467,5702,16614,02314,023N/A
12/31/202366,9011,38013,72113,721N/A
9/30/202363,4792,35510,84010,840N/A
6/30/202369,8963,03111,67511,675N/A
3/31/202368,7473,54213,03013,030N/A
12/31/202268,7645,09913,04413,044N/A
9/30/202273,2514,72616,08316,083N/A
6/30/202267,8735,14915,27915,279N/A
3/31/202270,9237,63413,14013,140N/A
12/31/202168,6886,65412,34712,347N/A
9/30/202170,4095,30112,40912,409N/A
6/30/202169,5194,41312,69612,696N/A
3/31/202165,0941,11511,28811,288N/A
12/31/202067,8425,19111,63911,639N/A
9/30/202065,5675,60311,66711,667N/A
6/30/202068,2307,12212,02012,020N/A
3/31/202071,6288,73813,56113,561N/A
12/31/201969,6205,72113,78613,786N/A
9/30/201968,1397,1959,9069,906N/A
6/30/201965,7505,9239,2939,293N/A
3/31/201969,4385,08412,51412,514N/A
12/31/201867,9414,98211,73811,738N/A
9/30/201868,1125,24412,48712,487N/A
6/30/201867,9805,235N/A13,688N/A
3/31/201862,1195,197N/A11,481N/A
12/31/201762,3084,893N/A12,283N/A
9/30/201759,2631,893N/A15,876N/A
6/30/201758,9082,044N/A14,069N/A
3/31/201757,2632,229N/A14,959N/A
12/31/201660,7323,481N/A14,774N/A
9/30/201665,2094,994N/A13,733N/A
6/30/201667,2555,169N/A13,445N/A
3/31/201669,9525,219N/A13,356N/A
12/31/201561,2573,891N/A14,052N/A
9/30/201571,8885,857N/A14,953N/A
6/30/201572,6776,724N/A16,343N/A
3/31/201574,5967,017N/A16,578N/A
12/31/201473,2656,190N/A16,376N/A
9/30/201472,6395,576N/A17,097N/A
6/30/201470,5144,452N/A15,738N/A
3/31/201468,3303,586N/A15,882N/A
12/31/201369,3963,244N/A16,131N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de MET ( 13.2% par an) est supérieure au taux d'épargne ( 2.6% ).

Bénéfices vs marché: Les bénéfices de MET ( 13.2% par an) devraient croître plus lentement que le marché US ( 15.4% par an).

Croissance élevée des bénéfices: Les bénéfices de MET devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de MET ( 4.4% par an) devrait croître plus lentement que le marché de US ( 9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de MET ( 4.4% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de MET devrait être faible dans 3 ans ( 16 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y